We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$71.1M
AUM Growth
+$4.73M
Cap. Flow
+$4.57M
Cap. Flow %
6.43%
Top 10 Hldgs %
34.33%
Holding
121
New
39
Increased
28
Reduced
18
Closed
35

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$1.64M
2
ELV icon
Elevance Health
ELV
+$1.57M
3
HCA icon
HCA Healthcare
HCA
+$1.56M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.45M
5
UHS icon
Universal Health Services
UHS
+$1.25M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$1.68M
2
MCK icon
McKesson
MCK
+$1.54M
3
PFE icon
Pfizer
PFE
+$1.38M
4
SYK icon
Stryker
SYK
+$1.34M
5
GILD icon
Gilead Sciences
GILD
+$1.16M

Sector Composition

Rank Sector Weight
1 Healthcare 49.97%
2 Technology 9.06%
3 Communication Services 7.08%
4 Industrials 6.17%
5 Financials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFX icon
26
Equifax
EFX
$20.8B
$981K 1.38%
10,100
-2,556
-20% -$249K
BHC icon
27
Bausch Health
BHC
$2.35B
$980K 1.38%
4,412
-7,575
-63% -$1.68M
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
$977K 1.37%
14,436
+155
+1% +$7.22K
ALDR
29
DELISTED
Alder Biopharmaceuticals
ALDR
$961K 1.35%
18,133
+2,742
+18% +$99.7K
ILMN icon
30
Illumina
ILMN
$30.2B
$946K 1.33%
4,455
-2,265
-34% -$442K
BIDU icon
31
Baidu
BIDU
$37.7B
$938K 1.32%
+4,710
New +$964K
HRTX icon
32
Heron Therapeutics
HRTX
$95.5M
$916K 1.29%
+29,405
New +$553K
RAD
33
DELISTED
Rite Aid Corporation
RAD
$901K 1.27%
5,397
+2
+0% +$336
MTG icon
34
MGIC Investment
MTG
$6.27B
$883K 1.24%
77,570
+16,797
+28% +$179K
NOW icon
35
ServiceNow
NOW
$121B
$862K 1.21%
+58,015
New +$895K
THOR
36
DELISTED
THORATEC CORPORATION
THOR
$786K 1.11%
17,644
+3,870
+28% +$169K
CTSH icon
37
Cognizant
CTSH
$25.1B
$780K 1.1%
+12,769
New +$802K
AERI
38
DELISTED
Aerie Pharmaceuticals
AERI
$770K 1.08%
43,623
+37,856
+656% +$694K
KYTH
39
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$760K 1.07%
10,098
-19,080
-65% -$1.02M
LNKD
40
DELISTED
LinkedIn Corporation
LNKD
$746K 1.05%
+3,608
New +$804K
HAL icon
41
Halliburton
HAL
$26.6B
$732K 1.03%
16,985
+11,501
+210% +$530K
QRVO icon
42
Qorvo
QRVO
$8.4B
$723K 1.02%
+9,007
New +$698K
JD icon
43
JD.com
JD
$43.9B
$711K 1%
+20,851
New +$709K
ACOR
44
DELISTED
Acorda Therapeutics
ACOR
$650K 0.91%
162
+65
+67% +$251K
FLS icon
45
Flowserve
FLS
$10.1B
$646K 0.91%
+12,269
New +$684K
OREX
46
DELISTED
Orexigen Therapeutics, Inc.
OREX
$630K 0.89%
12,735
+5,579
+78% +$334K
VAR
47
DELISTED
Varian Medical Systems, Inc.
VAR
$627K 0.88%
8,476
-3,162
-27% -$248K
JUNO
48
DELISTED
Juno Therapeutics, Inc.
JUNO
$544K 0.77%
10,194
-7,838
-43% -$416K
ZSPH
49
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$527K 0.74%
10,059
-11,988
-54% -$590K
ARAY icon
50
Accuray
ARAY
$32.8M
$518K 0.73%
76,925
+16,225
+27% +$121K
1
2
3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Partner Investment Management held 121 positions worth $71.1M, up 7.1% from $66.4M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Partner Investment Management deployed $4.57M of net new capital in Q2 2015, opening 39 new positions and adding to 28 existing holdings. Its largest new stake was Aetna Inc: 14,390 shares worth $1.83M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 52% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bausch Health, an estimated $1.68M trimmed.

  • Partner Investment Management's largest Q2 2015 buy was Aetna Inc: 14,390 shares worth $1.83M.
  • Partner Investment Management added most to HCA Healthcare in Q2 2015, an estimated $1.56M increase.
  • Partner Investment Management's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $1.68M.
  • Partner Investment Management fully exited McKesson in Q2 2015, selling an estimated $1.54M.
  • Partner Investment Management's ten largest holdings make up 34% of its $71.1M portfolio in Q2 2015.
  • Partner Investment Management opened 39 new positions and closed 35 in Q2 2015.
  • Partner Investment Management's portfolio value rose 7.1% quarter-over-quarter to $71.1M.

Based on Partner Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.